82
Views
7
CrossRef citations to date
0
Altmetric
Patent Evaluation

Pfizer's dual-acting β2 agonists/muscarinic M3 antagonists

Pfi zer: WO2008041095

, MBA PhD
Pages 1091-1096 | Published online: 21 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dramane I Lainé. (2010) Long-acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 3:1, pages 43-53.
Read now

Articles from other publishers (6)

Donald J. AbrahamJohn G. Montana, Hazel J. Dyke, J. Craig Fox & Nicholas C. Ray. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 47 .
Azizeh Abdolmaleki, Fereshteh Shiri & Jahan B. Ghasemi. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches 51 90 .
J. Richard Morphy. 2012. Designing Multi-Target Drugs. Designing Multi-Target Drugs 111 129 .
Giovanni Gaviraghi. 2010. Analogue-Based Drug Discovery II. Analogue-Based Drug Discovery II 319 331 .
Richard Morphy & Zoran Rankovic. 2010. Lead Generation Approaches in Drug Discovery. Lead Generation Approaches in Drug Discovery 141 164 .
Donald J. AbrahamJohn G. Montana, Hazel J. Dyke, J. Craig Fox & Nicholas C. Ray. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 747 790 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.